|
1
|
Ricchi P, Zarrilli R, Di Palma A and
Acquaviva AM: Nonsteroidal anti-inflammatory drugs in CRC: from
prevention to therapy. Br J Cancer. 88:803–807. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kobayashi H, Mochizuki H, Sugihara K, et
al: Characteristics of recurrence and surveillance tools after
curative resection for colorectal cancer, a multicenter study.
Surgery. 141:67–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tournigand C, André T, Achille E, Lledo G,
Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G,
Landi B, Colin P, Louvet C and de Gramont A: FOLFFIRI followed by
FOLFOX6 or the reverse sequence in advanced colorectal cancer: a
randomized GERCOR study. J Clin Oncol. 22:229–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ichikawa W, Uetake H, Shirota Y, Yamada H,
Nishi N, Nihei Z, Sugihara K and Hirayama R: Combination of
dihydropyrimidine dehydrogenase and thymidilate synthase gene
expressions in primary tumors as predictive parameters for the
efficacy of fluoropyrimidine-based chemotherapy for metastatic
colorectal cancer. Clin Cancer Res. 9:86–91. 2003.
|
|
5
|
Hengarter MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar
|
|
6
|
Wyllie AH: Apoptosis. Br J Cancer.
67:205–208. 1993.
|
|
7
|
Compagni A and Chiristofori G: Recent
advances in research on multistage tumorigenesis. Br J Cancer.
83:1–5. 2000.PubMed/NCBI
|
|
8
|
Makin G and Dive C: Apoptosis and cancer
chemotherapy. Trends Cell Biol. 11:S22–S26. 2001. View Article : Google Scholar
|
|
9
|
Fulda S and Debatin KM: Extrinsic vs.
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki H, Gabrielson E, Chen W, Anbazhagan
R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB: A
genomic screen for genes upregulated by demethylation and histone
deacetylase inhibition in human colorectal cancer. Nat Genet.
31:141–149. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kondo Y and Issa JP: Epigenetic changes in
colorectal cancer. Cancer Metastasis Rev. 23:29–39. 2004.
View Article : Google Scholar
|
|
12
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
13
|
Teodoridis JM, Strathdee G and Brown R:
Epigenetic silencing mediated by CpG island methylation: potential
as a therapeutic target and as a biomarker. Drug Resist Updat.
7:267–278. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishiguro M, Iida S, Uetake H, Morita S,
Makino H, Kato K, Takagi Y, Enomoto M and Sugihara K: Effect of
combined therapy with low-dose 5-aza-2′-deoxycytidine and
irinotecan on colon cancer cell line HCT-15. Ann Surg Oncol.
14:1752–1762. 2007.
|
|
15
|
Kato K, Iida S, Uetake H, Takagi Y,
Yamashita T, Inokuchi M, Yamada H, Kojima K and Sugihara K:
Methylated TMS1 and DAPK genes predict prognosis and response to
chemotherapy in gastric cancer. Int J Cancer. 122:603–608. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
R, Development Core Team. R, A language
and environment for statistical computing. R, Foundation for
Statistical Computing; Vienna, Austria: ISBN: 3-900051-07-0URL
http://www.R-project.org.
2006
|
|
17
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar
|
|
18
|
Eads CA, Danenberg KD, Kawakami K, Saltz
LB, Blake C, Shibata D, Danenberg PV and Laird PW: MethyLight: a
high-throughput assay to measure DNA methylation. Nucleic Acids
Res. 28:E322000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shirota Y, Stoehlmacher J, Brabender J,
Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg
PV and Lenz HJ: ERCC1 and thymidylate synthase mRNA levels predict
survival for colorectal cancer patients receiving combination
oxaliplatin and fluorouracil chemotherapy. J Clin Oncol.
19:4298–4304. 2001.
|
|
20
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumours. 6th edition. New York: Wiley;
2002
|
|
21
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. J Natl Cancer
Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tischoff I, Hengge UR, Vieth M, Ell C,
Stolte M, Weber A, Schmidt WE and Tannapfel A: Methylation of
SOCS-3 and SOCS-1 in the carcinogenesis of Barrett’s
adenocarcinoma. Gut. 56:1047–1053. 2007.PubMed/NCBI
|
|
23
|
Murai M, Toyota M, Suzuki H, et al:
Aberrant methylation and silencing of the BNIP3 gene in colorectal
and gastric cancer. Clin Cancer Res. 11:1021–1027. 2005.PubMed/NCBI
|
|
24
|
Hocker M, Schlenger K, Hockel S and Vaupel
P: Hypoxic cervical cancers with low apoptotic index are highly
aggressive. Cancer Res. 59:4525–4528. 1999.PubMed/NCBI
|
|
25
|
Hocker M and Vaupel P: Tumor hypoxia:
definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zagzag D, Zhong H, Scalziti JM, Laughner
E, Simons JW and Semenza GL: Expression of hypoxia-inducible factor
1α in brain tumors: association with angiogenesis, invasion, and
progression. Cancer. 88:2606–2618. 2000.
|
|
27
|
Blagosklonny MV: Antiangiogenic therapy
and tumor progression. Cancer Cell. 5:13–17. 2004. View Article : Google Scholar
|
|
28
|
Manka D, Spicer Z and Millhorn DE:
Bcl-2/Adenovirus E1B 19 kDa interacting protein-3 knockdown enables
growth of breast cancer metastases in the lung, liver, and bone.
Cancer Res. 65:11689–11693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bruick RK: Expression of the gene encoding
the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad
Sci USA. 97:9082–9087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo K, Searfoss G, Krolikowski D, Pagnoni
M, Franks C, Clark K, Yu KT, Jaye M and Ivashchenko Y: Hypoxia
induces the expression of the pro-apoptotic gene BNIP3. Cell Death
Differ. 8:367–376. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sowter HM, Ratcliffe PJ, Watson P,
Greenberg AH and Harris AL: HIF-1-dependent regulation of hypoxic
induction of the cell death factors BNIP3 and NIX in human tumors.
Cancer Res. 61:6669–6673. 2001.PubMed/NCBI
|
|
32
|
Bacon AL, Fox S, Turley H and Harris AL:
Selective silencing of the hypoxia-inducible factor 1 target gene
BNIP3 by histone deacetylation and methylation in colorectal
cancer. Oncogene. 26:132–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
De Angelis PM, Fjell B, Kravik KL, Haug T,
Tunheim SH, Reichelt W, Beigi M, Clausen OP, Galteland E and Stokke
T: Molecular characterizations of derivatives of HCT116 colorectal
cancer cells that are resistant to the chemotherapeutic agent
5-fluorouracil. Int J Oncol. 24:1279–1288. 2004.PubMed/NCBI
|
|
34
|
Kothari S, Cizeau J, McMillan-Ward E,
Israels SJ, Bailes M, Ens K, Kirshenbaum LA and Gibson SB: BNIP3
plays a role in hypoxic cell death in human epithelial cells that
is inhibited by growth factors EGF and IGF. Oncogene. 22:4734–4744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vande Velde C, Cizeau J, Dubik D, Alimonti
J, Brown T, Israels S, Hakem R and Greenberg AH: BNIP3 and genetic
control of necrosis-like cell death through the mitochondrial
permeability transition pore. Mol Cell Biol. 20:5454–5468.
2000.PubMed/NCBI
|
|
36
|
Okami J, Simeone DM and Logsdon CD:
Silencing of the hypoxia-inducible cell death protein BNIP3 in
pancreatic cancer. Cancer Res. 64:5338–5346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Murai M, Toyota M, Satoh A, Suzuki H,
Akino K, Mita H, Sasaki Y, Ishida T, Shen L, Garcia-Manero G, Issa
JP, Hinoda Y, Tokino T and Imai K: Aberrant DNA methylation
associated with silencing BNIP3 gene expression in haematopoietic
tumors. Br J Cancer. 92:1165–1172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tan KB, Mattern MR, Eng WK, McCabe FL and
Johnson RK: Nonproductive rearrangement of DNA Topoisomerase I and
II genes: correlation with resistance to topoisomerase inhibitors.
J Natl Cancer Inst. 81:1732–1735. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bras-Gonçalves RA, Rosty C, Laurent-Puig
P, Soulié P, Dutrillaux B and Poupon MF: Sensitivity to CPT-11 of
xenografted human colorectal cancers as a function of
microsatellite instability and p53 status. Br J Cancer. 82:913–923.
2000.PubMed/NCBI
|
|
40
|
Schmaltz C, Harrigan PH, Wells A and
Fisher DE: Regulation of proliferation-survival decisions during
tumor cell hypoxia. Mol Cell Biol. 18:2845–2854. 1998.PubMed/NCBI
|
|
41
|
Oizumi S, Isobe H, Ogura S, Ishida T,
Yamazaki K, Nishimura M, Kawakami Y and Dosaka-Akita H:
Topoisomerase inhibitor-induced apoptosis accompanied by down
regulation of Bcl-2 in human lung cancer cells. Anticancer Res.
22:4029–4037. 2002.PubMed/NCBI
|
|
42
|
Bani MR, Nicoletti MI, Alkharouf NW,
Ghilardi C, Petersen D, Erba E, Sausville EA, Liu ET and Giavazzi
R: Gene expression correlating with response to paclitaxel in
ovarian carcinoma. Mol Cancer Ther. 3:111–121. 2004.PubMed/NCBI
|
|
43
|
Erkan M, Kleeff J, Esposito I, Giese T,
Ketterer K, Büchler MW, Giese NA and Friess H: Loss of BNIP3
expression is a late event in pancreatic cancer contributing to
chemoresistance and worsened prognosis. Oncogene. 24:4421–4432.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Akada M, Crnogorac-Jurcevic T, Lattimore
S, Mahon P, Lopes R, Sunamura M, Matsuno S and Lemoine NR:
Intrinsic chemoresistance to gemcitabine is associated with
decreased expression of BNIP3 in pancreatic cancer. Clin Cancer
Res. 11:3094–3101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen G, Ray R, Dubik D, Shi L, Cizeau J,
Bleackley RC, Saxena S, Gietz RD and Greenberg AH: The E1B
19K/bcl-2-binding proteins Nip3 is a dimeric mitochondrial protein
that activates apoptosis. J Exp Med. 186:1975–1983. 1997.
View Article : Google Scholar : PubMed/NCBI
|
